T. May

Urolithiasis in HIV-Positive Patients Treated with Atazanavir

C. Couzigou, Michel Daudon, J.‐L. Meynard et al. · Clinical Infectious Diseases · 2007 · 97 citations · Full text

Protease Inhibitors, Urological Research, Urology +10

High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients

D. Rey, Bruno Hoën, P. Chavanet et al. · Journal of Antimicrobial Chemotherapy · 2008 · 57 citations · Full text

Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor--Containing Therapy

Xavier Duval, Valérie Journot, C. Leport et al. · Clinical Infectious Diseases · 2004 · 55 citations · Full text

Immunology, Pharmacotherapy, Adverse Drug Reaction +20

Comparative efficacy of sparfloxacin in comparison with amoxycillin plus ofloxacin in the treatment of community-acquired pneumonia

H. Portier, T. May, A. J. Proust · Journal of Antimicrobial Chemotherapy · 1996 · 44 citations · Full text

Community-acquired Pneumonia, Health Sciences, Antibiotics +13

Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.

T. May, C. Beuscart, Jacques Reynes et al. · PubMed · 1994 · 39 citations

Pharmacotherapy, Antimicrobial Chemotherapy, Drug Resistance +20